Suppression of Neurodegeneration and Increased Neurotransmission Caused by Expanded Full-Length Huntingtin Accumulating in the Cytoplasm  by Romero, Eliana et al.
Neuron
ArticleSuppression of Neurodegeneration and Increased
Neurotransmission Caused by Expanded Full-Length
Huntingtin Accumulating in the Cytoplasm
Eliana Romero,1,7 Guang-Ho Cha,1,7 Patrik Verstreken,1,2,4,7,8 Cindy V. Ly,3 Robert E. Hughes,6
Hugo J. Bellen,1,2,3,4 and Juan Botas1,5,*
1Department of Molecular and Human Genetics
2Howard Hughes Medical Institute
3Department of Neuroscience
4Program in Developmental Biology
5Department of Molecular and Cellular Biology
Baylor College of Medicine, Houston, TX 77030, USA
6Buck Institute, 8001 Redwood Boulevard, Novato, CA 94945, USA
7These authors contributed equally to this work.
8Present address: VIB Department of Molecular and Developmental Genetics, Katholieke Universiteit Leuven Department of Human
Genetics, Herestraat 49, bus 602, B3000 Leuven, Belgium.
*Correspondence: jbotas@bcm.tmc.edu
DOI 10.1016/j.neuron.2007.11.025SUMMARY
Huntington’s disease (HD) is a dominantly inherited
neurodegenerative disorder caused by expansion
of a translated CAG repeat in the N terminus of the
huntingtin (htt) protein. Here we describe the genera-
tion and characterization of a full-length HD Droso-
phila model to reveal a previously unknown disease
mechanism that occurs early in the course of patho-
genesis, before expanded htt is imported into the
nucleus in detectable amounts. We find that ex-
panded full-length htt (128QhttFL) leads to behavioral,
neurodegenerative, and electrophysiological pheno-
types. These phenotypes are caused by a Ca2+-de-
pendent increase in neurotransmitter release effi-
ciency in 128QhttFL animals. Partial loss of function
in synaptic transmission (syntaxin, Snap, Rop) and
voltage-gated Ca2+ channel genes suppresses both
the electrophysiological and the neurodegenerative
phenotypes. Thus, our data indicate that increased
neurotransmission is at the root of neuronal degener-
ation caused by expanded full-length htt during early
stages of pathogenesis.
INTRODUCTION
Expansion of the glutamine tract of huntingtin (htt) invariably
leads to psychiatric, motor, and cognitive disturbances. Most
Huntington’s disease (HD) patients become symptomatic late
in life, but large expansions of the glutamine tract (>70 repeats)
lead to juvenile forms of the disease, which demonstrates an in-
verse relationship between repeat size and disease onset (The
Huntington’s Disease Collaborative Research Group, 1993).
Glutamine-expanded htt forms ubiquitin-positive aggregates inthe nuclei and neurites of brain neurons (DiFiglia et al., 1997; Ru-
binsztein, 2002). Wild-type htt is a large (350 kDa) soluble protein
that is conserved between Drosophila and mammals and is
detected in neurons and other cell types. Htt is most abundant
in the cytoplasm, where it associates with the Golgi complex,
endoplasmic reticulum, and synaptic vesicles (Cattaneo et al.,
2005). Although essential for murine embryogenesis (Nasir
et al., 1995), its normal functions are still poorly understood.
Protein interaction analyses implicate htt in diverse processes,
including intracellular trafficking, axonal transport, transcrip-
tional regulation, cytoskeletal organization, and prevention of
apoptosis (Goehler et al., 2004; Harjes and Wanker, 2003; Kal-
tenbach et al., 2007; Li and Li, 2004b). Htt has also been linked
to neurotransmission (reviewed in Harjes and Wanker, 2003;
Li et al., 2003; Smith et al., 2005). For example, htt associates
with clathrin-coated pits and vesicles at synaptic terminals (DiFi-
glia et al., 1995; Velier et al., 1998). Increased neuronal input
resistance, lower stimulus intensity to evoke action potentials
(Klapstein et al., 2001), impaired long-term potentiation (Hodg-
son et al., 1999; Klapstein et al., 2001; Murphy et al., 2000; Usdin
et al., 1999), and abnormal responses to NMDA stimulation
(Cepeda et al., 2001; Laforet et al., 2001) in HD neurons suggest
that synaptic dysfunction may contribute to pathogenesis. Stud-
ies in the R6/2 N-terminal mouse model have shown alterations
in the corticostriatal pathway and altered levels of postsynaptic
markers (Cepeda et al., 2003). However, it is unclear whether
alterations in synaptic function are early events or secondary to
neuronal dysfunction during pathogenesis.
Mouse models for HD include transgenic animals expressing
either truncations of htt or the entire protein, and ‘‘knockins’’
expressing the endogenous murine protein with an expanded
polyglutamine tract (reviewed in Menalled, 2005; Menalled and
Chesselet, 2002; Rubinsztein, 2002). Most studies have been
conducted using the first generated models that only express
a small N-terminal portion of the protein (exon 1) containing the
polyglutamine expansion. Mice expressing short truncations ofNeuron 57, 27–40, January 10, 2008 ª2008 Elsevier Inc. 27
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notypes than mice expressing the entire protein. They also show
formation of nuclear aggregates early in life. Full-length or longer
N-terminal models exhibit cytoplasmic accumulation of htt, and
the nuclear localization or aggregation occurs only later in life
(Hickey and Chesselet, 2003; Menalled, 2005; Menalled et al.,
2002; Rubinsztein, 2002; Van Raamsdonk et al., 2005). More-
over, N-terminal mouse models fail to reproduce the specificity
of neuronal degeneration observed in HD patients, where neuro-
nal loss occurs mainly in the striatum and cortex (Li and Li,
2004a). This selective neurodegeneration is best reproduced in
models that express the full-length protein (Van Raamsdonk
et al., 2005).
Drosophila HD models have been used to demonstrate that
nuclear (i.e., transcriptional dysregulation [Steffan et al., 2001]),
and nonnuclear (i.e., fast axonal transport [Lee et al., 2004])
mechanisms of pathogenesis, as well as posttranslational mod-
ifications of htt, are important for pathogenesis (Steffan et al.,
2004). They have also been used to identify chemical com-
pounds that may ameliorate htt-induced toxicity (Bilen and
Bonini, 2005; Marsh and Thompson, 2004; Sang and Jackson,
2005). However, no full-length model of HD has been reported
in Drosophila.
Studies using N-terminal models have provided many impor-
tant insights into HD; however, it is clear that protein context is
important for pathogenesis (Yu et al., 2003). This is best illus-
trated by a transgenic mouse expressing 120 CAG repeats in
the context of exons 1 and 2 of the htt protein, which shows
no neuronal dysfunction or degeneration despite abundant neu-
ronal inclusions (Slow et al., 2005). The importance of appropri-
ate protein context has also been documented in the case of
other polyglutamine diseases (Gatchel and Zoghbi, 2005).
Here we report the development of a full-length Drosophila HD
model to investigate the mechanisms by which expanded full-
length htt impairs synaptic transmission. We show that expres-
sion of expanded full-length htt leads to an increased neurotrans-
mitter release efficiency. This phenotype can be suppressed
genetically by removing a single copy of the genes encoding
the proteins that are required for proper neurotransmitter re-
lease. We find that resting intracellular Ca2+ levels are increased
in these flies when compared to controls. This suggests a defect
in Ca2+ homeostasis, which is in agreement with observations in
mammalian systems (Bezprozvanny and Hayden, 2004; Cepeda
et al., 2001; Hodgson et al., 1999; Tang et al., 2005). Importantly,
these abnormalities occur before we can detect the cleavage
and nuclear translocation of the htt protein. We also show that
mutations in certain voltage-gated Ca2+ channels restore the
elevated Ca2+ levels and improve neurotransmitter release effi-
ciency and neurodegenerative phenotypes.
RESULTS
Full-Length Human htt Accumulates
in the Cytoplasm of Drosophila Neurons
and Does Not Form Visible Aggregates
We generated transgenes to express the entire 3144 aa human
protein with either 16 (16QhttFL, wild-type) or 128 (128QhttFL,
pathogenic) glutamines under the control of the UAS-GAL428 Neuron 57, 27–40, January 10, 2008 ª2008 Elsevier Inc.system (Brand and Perrimon, 1993). Western analyses revealed
a band corresponding to the 350 kDa full-length protein in
Drosophila expressing either the 16QhttFL or the 128QhttFL
transgenes with the GMR-GAL4 eye driver. In contrast, no
such protein was detected in GMR-GAL4 controls. The 16QhttFL
protein runs slightly faster than the 128QhttFL protein, as may
be expected from the different number of glutamine repeats
(Figure 1A).
To determine the intracellular localization of full-length htt in
Drosophila,we used a GAL4 driver directing expression to a spe-
cific subset of large central nervous system (CNS) neurons, the
apVNC interneurons (Fernandez-Funez et al., 2000). Labeling us-
ing MAB5374 shows cytoplasmic accumulation of both 16QhttFL
and 128QhttFL in apVNC interneurons of 20-day-old flies (Fig-
ure 1B, left and central panels). Similar results were observed
in 10-day-old and 30-day-old flies (data not shown). The ab-
sence of detectable nuclear htt staining is not a consequence
of this antibody’s inability to detect htt in the nucleus because
flies expressing an N-terminal truncated form of the protein
(amino acids 1–208) with the same glutamine expansion show
robust nuclear staining using the same antibody concentration
and experimental conditions (Figure 1B, right panels; see also
Jackson et al. [1998] and Steffan et al. [2001] for nuclear staining
of similarly sized htt fragments inDrosophila). Thus, the cytoplas-
mic accumulation of 128QhttFL is reminiscent of data from HD
murine models wherein full-length htt localizes to the cytoplasm
first, and nuclear staining is only evident months after birth (Me-
nalled, 2005; Rubinsztein, 2002; Slow et al., 2003), a time well
beyond the lifespan of flies.
We subsequently investigated whether full-length htt forms
aggregates in Drosophila neurons. Large axonal aggregates
blocking axonal transport have been reported in flies expressing
an expanded N-terminal htt fragment of 548 amino acids (Lee
et al., 2004). In contrast to 128Qhtt1-548 (Figure 1C, lower right
panel), 128QhttFL does not form obvious axonal aggregates
(Figure 1C, lower left panel). To investigate whether axonal trans-
port is impaired in 128QhttFL flies, we monitored the localization
of synaptotagmin I, a synaptic vesicle-associated protein that is
transported along axons (Lee et al., 2004). We found that in
animals expressing 128Qhtt1-548, synaptotagmin I, like htt, accu-
mulates in the axons (Figure 1D, lower right panel). In contrast,
larvae expressing the control protein GFP (Figure 1D, upper
left panel) or the full-length htt protein (expanded or unexpanded)
(Figure 1D, lower left and upper right panels, respectively) do not
show accumulation of synaptotagmin I in axons. Thus, although
it is difficult to exclude the possibility of decreased axonal trans-
port, we found no evidence of axonal blockages disrupting trans-
port in 128QhttFL-expressing animals.
Expression of 128QhttFL, but Not 16QhttFL,
in the Drosophila Eye and CNS Leads to Progressive
Neurodegenerative Phenotypes
To examine the consequences of expressing full-length htt in
the visual system, the 16QhttFL and 128QhttFL transgenes were
expressed using GMR-GAL4 drivers. Examination of the external
eye morphology using light microscopy and scanning electron
microscopy (SEM) revealed depigmentation and disorganiza-
tion of ommatidia following expression of 128QhttFL(s) but not
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Drosophila Neurons and Does Not Form Visible Axonal Aggregates
(A) Western analysis of transgenic Drosophila heads using MAB2166 reveals
a (350 KDa) band corresponding to full-length (unexpanded and expanded)
human htt. Based on densitometry analysis, the 16Q line expresses higher/sim-
ilar protein levels than the 128Q(w) and 128Q(s) lines (2-fold and 1-fold,
respectively). Genotypes: GMR (GMR-GAL4/UAS-GFP), GMR-16QhttFL
(GMR-GAL4/UAS-16QhttFL[M28]), GMR-128QhttFL(w) (GMR-GAL4/+; UAS-
128Qhtt(w)[F7]/+), GMR-128QhttFL(s) (GMR-GAL4/UAS-128Qhtt(s)[M36E2]).
(B) Immunofluorescence confocal images ofDrosophila apterous ventral nerve
cord interneurons from 20-day-old flies expressing wild-type (left, 16QhttFL) or
expanded (middle, 128QhttFL) full-length htt. Right panels show similar images
from animals expressing an expanded N-terminal htt truncation (amino acids
1–208 excluding the polyglutamine tract, 128Qhtt1-208). Note colocalization of
full-length htt with the CD8-GFP cytoplasmic marker. The same results
were obtained with 10-day-old and 30-day-old flies (data not shown). In
contrast, 128Qhtt1-208 accumulates in the nucleus as early as the third-instar
larval stage. MAB5374 was used at 1:100 for all stainings, which were done
simultaneously. Flies raised at 27C. Scale bar, 5 mm. Genotypes: 16QhttFL
(UAS-16QhttFL[M28]/UAS-CD8-GFP; apVNC-GAL4/+), 128QhttFL (UAS-
128QhttFL(s)[M36E2]/UAS-CD8-GFP; apVNC-GAL4/+), 128Qhtt1-208 (UAS-
CD8-GFP/+; UAS-128Qhtt1-208[M64]/apVNC-GAL4).
(C and D) Immunolabeling of htt (C) or endogenous synaptotagmin I (Syt) (D)
proteins in motor neuron axon bundles from third-instar larvae of the genotype
indicated in each panel. Note diffuse pattern and absence of aggregates in
wild-type (16QhttFL) and expanded htt (128QhttFL) axons. In contrast, a long16QhttFL from GMR-GAL4(s), a relatively strong driver (Figures
2A–2D, left and center panels).
To investigate whether the eye phenotype is progressive, the
same htt transgenes were expressed using a weaker GMR-
GAL4 eye driver to facilitate comparison of the internal retinal
structure between animals of different genotypes. Phalloidin
staining of dissected wild-type eyes reveals the organization of
the Drosophila eye in ommatidia. Each ommatidium contains
eight rhabdomeres (the rod-shaped structures where the photo-
pigment rhodopsin accumulates in photoreceptor neurons),
seven of which are typically visible in a single plane (Figure 2A,
right panel). Because retinal degeneration often results in fewer
rhabdomeres, we compared the number of rhabdomeres per
ommatidium in 1-day-old and 20-day-old animals expressing
128QhttFL, 16QhttFL, or a lacZ control transgene. In 1-day-old
flies, we observed no differences between the distributions of
rhabdomeres in these genotypes, with seven rhabdomeres visi-
ble in most ommatidia (Figure 2E). However, in flies aged for 20
days, we found significantly fewer rhabdomeres in 128QhttFL
flies than in 16QhttFL and lacZ control flies (right panels of Figures
2A–2D and Figure 2F, p < 0.0001, Mann-Whitney test). Thus, the
analyses of both external and internal eye phenotypes caused by
full-length htt using two GMR-GAL4 drivers of different strengths
yielded similar results. Furthermore, expression of 128QhttFL
leads to progressive degeneration of photoreceptor cells.
We also investigated the consequences of expressing
128QhttFL in CNS neurons. First, we compared the survival rates
of 128QhttFL and GFP control animals following transgene ex-
pression in motor neurons using the C164-GAL4 driver (Pennetta
et al., 2002). As shown in Figure 3A, flies expressing 128QhttFL
show reduced survival in adult life when compared with controls
expressing GFP (p < 0.05, p < 0.01, and p < 0.01 for days 25, 30,
and 35, respectively, Mann-Whitney test).
We then compared motor performance in 128QhttFL and con-
trol animals. First we measured motor performance in a climbing
assay that exploits the strong negative geotaxis behavior of Dro-
sophila. This assay measures the ability of flies to climb a vial wall
as a function of age. As shown in Figure 3B, we found impaired
motor performance in 128QhttFL flies as compared with controls
expressing GFP. In addition, we used a flight assay to measure
the flying ability of 128QhttFL flies. Flying ability is determined
as a function of flight distance after flies are dropped from the
top of a transparent cylinder (Pesah et al., 2004). We found
that 25-day-old 128QhttFL flies exhibit a severe flight-impairment
phenotype, while GFP control and 16QhttFL flies of the same age
behave normally (Figure 3C).
To substantiate a correlation between neurodegeneration and
flight impairments in the 128QhttFL-expressing flies, we investi-
gated the neuronal projections into the Indirect Flight Muscles
(IFM). Labeling of the motor neurons innervating the IFM shows
a neurodegenerative phenotype in aged 128QhttFL flies, but not
16QhttFL control flies of the same age (Figures 3D and 3E,
N-terminal htt truncation (amino acids 1–548, 128Qhtt1-548) causes large htt
and synaptotagmin I axonal aggregates. MAB5374 1:100. Flies were at 29C.
Scale bar, 5 mm. Genotypes: GFP (Elav-GAL4/+; UAS-GFP/+), 16QhttFL (Elav-
GAL4/+; UAS-16QhttFL[M28]/+), 128QhttFL (Elav-GAL4/+; UAS-128QhttFL
(s)[M36E2]/+), 128Qhtt1-548 (Elav-GAL4/+; UAS-128QHtt1-548/+).Neuron 57, 27–40, January 10, 2008 ª2008 Elsevier Inc. 29
Neuron
Reversing Htt-Induced Increased NeurotransmissionFigure 2. Progressive Neurodegenerative Eye
Phenotype Produced by Overexpression of Ex-
panded (128Q), but Not Unexpanded (16Q), Full-
Length htt
(A–D) Light microscope (left) and SEM (center) images of
transgenic flies expressing (A) nontoxic LacZ control pro-
tein, (B) wild-type htt, (C) low levels of expanded htt, and
(D) high levels of expanded htt. Insets in SEM images
show magnification (6003) of ommatidia. Note disorgani-
zation of ommatidia in (D). Right panels show phalloidin
staining of the corresponding eyes from 20-day-old flies
showing arrangement of rhabdomeres. Flies for light mi-
croscope and SEM images were raised at 25C. Flies for
phalloidin staining were raised at 27C. Genotypes for light




[M36E2]). Genotypes for phalloidin staining: GMR-lacZ
(GMR-GAL4/UAS-lacZ), GMR-16QhttFL (GMR-GAL4/UAS-
16QhttFL[M28]), GMR-128QhttFL (GMR-GAL4/+; UAS-
128QhttFL(w)[F7]), GMR-128QhttFL (GMR-GAL4/UAS-
128QhttFL[M36E2]).
(E and F) Quantification of the number of rhabdomeres per
ommatidium in 1-day-old (E) or 20-day-old (F) flies express-
ing the following proteins. Green, nontoxic LacZ control;
yellow, wild-type htt; red, expanded htt at relatively low
levels; black, expanded htt at relatively high levels. Flies
raised at 27C. n = 100 ommatidia per genotype. The distri-
bution of the rhabdomeres at day 20 for 128QhttFL(w)
and 128QhttFL(s) is significantly different from LacZ and 16QhttFL controls (p < 0.001, Mann-Whitney test). Genotypes: GMR-lacZ (GMR-GAL4/UAS-lacZ),
GMR-16QhttFL (GMR-GAL4/UAS-16QhttFL[M28]), GMR-128QhttFL(w) (GMR-GAL4/+; UAS-128QhttFL(w)[F7]), GMR-128QhttFL(s) (GMR-GAL4/UAS-
128QhttFL(s)[M36E2]).p < 0.05, Mann-Whitney test). Together, these data indicate that
expression of expanded full-length htt causes progressive de-
generative phenotypes in PNS and CNS neurons in Drosophila.
Htt Is Unevenly Distributed across Synaptic Boutons,
but Does Not Affect the Distribution
of Key Synaptic Proteins
We investigated the mechanism by which 128QhttFL triggers the
eye and CNS phenotypes described above. Potentially impor-
tant mechanisms of pathogenesis in HD are transcriptional dys-
regulation (Sugars and Rubinsztein, 2003), impaired axonal
transport (Gunawardena and Goldstein, 2005; Li and Li,
2004a), synaptic dysfunction (Smith et al., 2005), and abnormal
Ca2+ homeostasis (Bezprozvanny and Hayden, 2004). Because
we did not detect 128QhttFL nuclear accumulation or axonal
aggregation of 128QhttFL or synaptotagmin, we focused on syn-
aptic dysfunction and Ca2+ homeostasis.
First we studied the distribution of full-length htt in synaptic
terminals. Interestingly, htt, driven by the Elav-GAL4 panneural
driver exhibits a nonuniform distribution across boutons within
a single third-instar larval neuromuscular junction (NMJ) (Fig-
ure 4A). We also studied the distribution of proteins involved in
synaptic transmission in 128QhttFL and control animals. Fig-
ure 4B shows that soluble NSF-attachment protein, Snap (Ord-
way et al., 1994), Ras opposite (Rop) (Schulze et al., 1994), and
syntaxin 1A (Syx) (Schulze et al., 1995) are normally distributed
in boutons expressing 128QhttFL. Also, we did not observe no-
ticeable abnormalities in bouton number, branching, or morphol-30 Neuron 57, 27–40, January 10, 2008 ª2008 Elsevier Inc.ogy in 128QhttFL larvae (data not shown). In 128QhttFL flies, htt is
expressed in the presynaptic neurons and is not present in the
postsynaptic muscles. Therefore, we do not expect significant
changes in postsynaptic glutamate receptor clusters. Nonethe-
less, to visualize neurotransmitter receptor clusters at the NMJ,
we labeled 128QhttFL and 16QhttFL control flies with GluRIIA an-
tibodies (Schuster et al., 1991). Receptor cluster abundance is
not significantly different in 128QhttFL and 16QhttFL animals (Fig-
ure 4B, uppermost row panels, p > 0.5, Mann-Whitney test).
Hence, postsynaptic neurotransmitter receptor clustering ap-
pears unaffected by neuronal expression of expanded full-length
htt. These observations suggest that abnormal bouton morphol-
ogy, altered synaptic protein accumulation, or both together are
not responsible for the eye and CNS phenotypes observed in
128QhttFL flies.
Increased Neurotransmitter Release Probability
upon Expression of 128QhttFL
Because the immunolabeling studies of the NMJ using confocal
microscopy did not reveal major differences in abundance or dis-
tribution of synaptic proteins between 128QhttFL and control an-
imals, we investigated possible electrophysiological defects. To
determine the properties of neurotransmitter release in neurons
expressing 128QhttFL presynaptically, we recorded excitatory
junctional potentials (EJPs) at the third-instar larval NMJ. Al-
though EJPs recorded from animals expressing either 128QhttFL
or GFP in the nervous system (Elav-128QhttFL or Elav-GFP, re-
spectively) are similar at 1.2 mM extracellular Ca2+ (Elav-GFP:
Neuron
Reversing Htt-Induced Increased NeurotransmissionFigure 3. Reduced Survival, ImpairedMotor Performance, and Neuronal Degeneration inDrosophila Expressing Expanded Full-Length htt in
the CNS
(A) Average survival of flies expressing GFP (dark bars) or 128QhttFL (light bars) in the CNS (C164-GAL4) at days 25, 30, and 35. The survival rate of flies expressing
128QhttFL is significantly lower than the survival rate of control flies expressing a nontoxic GFP protein (p < 0.05, p < 0.01, and p < 0.01, respectively, Mann-Whit-
ney test). Dots denote single data points for individual populations. Error bars = SEM; n = 7 and 10 populations for GFP and 128QhttFL, respectively.
(B) Climbing performance as a function of age in control and 128QhttFL-expressing flies. Normal decline in climbing performance is observed after day 25 in flies
expressing the nontoxic GFP protein (silver line). In contrast, flies expressing 128QhttFL (black lines) perform poorly after day 20. All flies raised at 27C. Two
independent experiments are shown for flies expressing 128QhttFL. Error bars = SEM of ten trials per time point.
(C) Flying ability in 25-day-old control and htt-expressing flies. Flying ability is represented in arbitrary units, with 12 being a perfect ability and 0 being no ability.
Note that most control flies that carry only the motor neuron driver (silver line) or express wild-type htt (16QhttFL, gray dotted lines) perform well in this assay, with
no significant difference between them (p > 0.1, Mann-Whitney test). Most flies expressing expanded htt (128QhttFL, black lines), on the other hand, show im-
paired flying ability when compared to either control (p < 0.05, Mann-Whitney test).
(D) Stacks of confocal images of neurons projecting into indirect flight muscles (IFM) 3 and 4 of 10-day (upper panels) and 25-day (lower panels) -old flies ex-
pressing wild-type (left) or expanded (right) htt. Note the loss of neuronal projections and NMJs in flies expressing expanded htt. Scale bar, 10 mm.
(E) Quantification of the number of neuronal projections in a specified 100 mm3 100 mm area of IFM 3/4 shown in (D). 20-day and 25-day, but not 10-day old flies
expressing 128QhttFL have significantly fewer neuronal projections than control flies of the same age expressing wild-type 16QhttFL protein (ns: p > 0,05;
*p < 0.05, Student’s t test; n = 5).
All flies raised at 27C. Genotypes: C164 (C164-GAL4/+), C164-GFP (C164-GAL4/UAS-GFP), C164-16QhttFL (C164-GAL4/UAS-16QhttFL[M28]), C164-
128QhttFL (C164-GAL4/UAS-128QhttFL(s)[M36E2]).40.5 ± 2.0 mV; Elav-128QhttFL: 44.2 ± 0.6 mV; t test, p > 0.1, data
not shown), EJPs recorded at lower extracellular Ca2+ are clearly
different. As shown in Figures 5A–5C, EJPs recorded from Elav-
128QhttFL animals in 0.25 mM Ca2+ are increased about 5-fold
compared with those of Elav-GFP controls (Elav-GFP: 2.9 ±
0.3 mV; Elav-128QhttFL: 16.0 ± 2.7 mV; t test, p < 0.001), whereas
EJPs recorded in 0.6 mM Ca2+ are increased by 30% (Elav-
GFP: 27.7 ± 3.0 mV; Elav-128QhttFL: 36.3 ± 2.4 mV; t test, p <
0.05). The increased neurotransmission is specific to expression
of 128QhttFL because expression of wild-type 16QhttFL does not
produce this effect (Figures 5B and 5C; Elav-16QhttFL in 0.25 mM
Ca2+: 3.6 ± 0.8 mV; t test, p > 0.7). This phenotype is not simply an
effect of the 128QhttFL transgene insertion site because flies car-
rying the transgene in the absence of the Elav driver do not differ
from GFP controls (128QhttFL: 3.08 ± 0.63 mV; Elav-GFP: 2.9 ±
0.3 mV). Thus, expression of expanded htt protein in neurons
leads to increased synaptic transmission at the NMJ of third-
instar Drosophila larvae.Because our data argue against abnormal glutamate receptor
clustering (see above), the increased synaptic transmission in
128QhttFL animals could be caused by increased neurotransmit-
ter release from individual synaptic vesicles or increased release
efficiency. To test whether neurotransmitter release from single
vesicles is altered in Elav-128QhttFL animals, we recorded spon-
taneous fusion events in the absence of stimulation (mEJPs or
minis; 0.1 mM Ca2+ and 5 M TTX). As shown in Figures 5D and
5E, mEJP frequency and amplitude are similar in Elav-128QhttFL
and Elav-GFP animals, indicating that transmitter loading and
postsynaptic glutamate receptor clustering are unaffected.
Finally, to determine release probability, we recorded the
number of failures (nonevents) when motor neurons were stimu-
lated two to three times above threshold in low (0.25 mM) Ca2+.
Interestingly, whereas controls (Elav-GFP, Elav-16QhttFL, and
128QhttFL with no driver) fail to release about 20%–25% of the
time (Figure 5F), animals that express 128QhttFL reliably release
neurotransmitter upon stimulation, with very low failure ratesNeuron 57, 27–40, January 10, 2008 ª2008 Elsevier Inc. 31
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aptic transmission observed in animals that express 128QhttFL is,
at least in part, caused by an increase in neurotransmitter release
probability.
Partial Loss of Function of Genes Required for Proper
Synaptic Transmission Suppresses Neurotransmitter
Release Abnormalities Caused by 128QhttFL
Because expression of 128QhttFL causes increased synaptic
transmission and release probability, an attractive possibility is
that reducing the activity of components of the neurotransmitter
release machinery may ameliorate these phenotypes, providing
a potential therapeutic strategy.
To test this hypothesis, we recorded EJP amplitudes in
0.25 mM Ca2+ and determined the release probability in 128QhttFL
flies that lack one functional copy of Soluble NSF attachment
protein (Snap), syntaxin1A (Syx), or proteins that are known to
bind Syx, like Rop (Schulze et al., 1994) and Vha100-1 (Hiesinger
et al., 2005). Syx is a plasma membrane-associated member of
the SNARE complex that mediates fusion between the vesicular
and synaptic membranes (Schulze et al., 1995). Snap associates
with the SNARE complex and assists N-ethylmaleimide Sensitive
Fusion Protein (NSF) in the dissociation of SNARE complexes
(Ordway et al., 1994). Rop, the Drosophila Sec1 homolog, inter-
acts with syntaxin in vivo and has both positive and inhibitory
functions on neurotransmission (Wu et al., 1998). Whereas
animals that overexpress 128QhttFL in the nervous system
show increased EJP amplitude and decreased failure rate (Fig-
ure 5B and 5F), removing one copy of Snap (Elav-GAL4/+;
Figure 4. Uneven Distribution of Full-Length htt across
Boutons Does Not Affect Distribution of Key Synaptic
Proteins
(A) Immunofluorescence confocal images of NMJs from third-
instar larvae expressing wild-type (left) or expanded (right) htt re-
veal its uneven distribution from one bouton to another within in-
dividual axons. Boutons are visualized with anti-synaptotagmin
antibody (green), and htt is labeled in red. Scale bar, 10 mm.
(B) Immunofluorescence confocal images of NMJs from third-in-
star larvae expressing wild-type (left) or expanded (right) htt
show morphologically normal boutons with no abnormal distri-
bution of proteins involved in neurotransmitter secretion.
Boutons are visualized with anti-dlg (green) and stained for
(from top to bottom) GluRIIA, Rop, Snap, and Syx (red). No differ-
ences are detected in the patterns of accumulation of any of
these proteins in boutons from larvae expressing expanded htt
or boutons from control larvae expressing wild-type htt (p >
0.5, p > 0.1, p > 0.1, and p > 0.1, respectively). Scale bar, 5 mm.
All larvae raised at 29C. Genotypes: 16QhttFL (Elav-GAL4/+;
UAS-16QhttFL(s)[M28]/+), 128QhttFL (Elav-GAL4/+; UAS-
128QhttFL(s)[M36E2]/+).
UAS-128QhttFL(s)[M36E2]/+; SnapM4/+) suppresses
these phenotypes and restores the EJP amplitude
and failure rates to control levels (Figures 6A, 6B, 6I,
and 6L). This suppression effect is not a result of re-
duced transmission in animals that have lost one
copy of Snap, because the EJP amplitude and failure
rates in Elav-GAL4/+; SnapM4/+ larvae are not different from con-
trols (Elav-GAL4/+; UAS-GFP/+) (Figures 6A, 6B, 6J, and 6K).
Similarly, although removing one copy of Rop (Elav-GAL4/+;
RopG27/+) (Figures 6C, 6D, 6M, and 6N) or one copy of Syx
(Elav-GAL4/+; Syx229/+) (Figures 6E and 6F) does not affect EJP
amplitudes or failure rates compared with controls at 0.25 mM
Ca2+, it efficiently suppresses the increased EJP amplitude and
decreased failure rates observed in Elav-128QhttFL animals.
Not all components of the release machinery are able to sup-
press the increased release in Elav-128QhttFL larvae to the same
extent. The Vha100-1 subunit is an important component of the
synaptic vesicle release machinery, recently shown to act down-
stream of the SNARE complex in neurons (Hiesinger et al., 2005).
Removing one copy of Vha100-1 in 128QhttFL-expressing ani-
mals (Elav-GAL4/+; UAS-128QhttFL(s)[M36E2]/+; vha1/+) does
not fully suppress the increased EJP amplitude seen in Elav-
128QhttFL larvae and fails to suppress the increased release
probability (Figures 6G and 6H). Taken together, these data sug-
gest that neuronal expression of expanded htt facilitates neuro-
transmitter release by acting upon a general process that pro-
motes vesicle release.
Synaptic Transmission Mutations Also Suppress
the Eye Neurodegeneration and Motor Performance
Phenotypes Caused by 128QhttFL
If increased neurotransmitter release is an important mechanism
by which expanded full-length htt exerts its toxicity on 128QhttFL
flies, one may expect that suppressors of the electrophysiologi-
cal phenotype also suppress other defects observed in these32 Neuron 57, 27–40, January 10, 2008 ª2008 Elsevier Inc.
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Reversing Htt-Induced Increased Neurotransmissionanimals. To test this hypothesis, we assessed the ability of neu-
rotransmitter release mutations to suppress the degenerative
phenotype observed in eye photoreceptors of 128QhttFL flies.
At 20 days, flies expressing 128QhttFL (GMR-GAL4/+; UAS-
128QhttFL(w)[F7]/+) show fewer rhabdomeres per ommatidium
Figure 5. Neurotransmitter Release Probability Is Increased upon
Expression of Full-Length Expanded htt
(A and B) Quantification of EJP amplitudes recorded at (A) 1 Hz in 0.6 mM Ca2+
or (B) 0.25 mM Ca2+ in Drosophila larvae expressing a nontoxic control protein
(GFP), wild-type, or expanded full-length htt or controls carrying the htt trans-
gene without a GAL4 driver. ns: p > 0.05; *p < 0.05; **p < 0.01 throughout the
figure.
(C) Sample EJP traces recorded from Drosophila larvae expressing GFP con-
trol protein and expanded full-length htt in HL3 buffer at 0.6 mM Ca2+ (top) or
0.25 mM Ca2+ (bottom). For 0.25 mM Ca2+, sample traces are also shown for
transgenic larvae expressing wild-type htt and for controls carrying the ex-
panded htt transgene without a GAL4 driver. Arrows indicate blanked-out
stimulus artifact.
(D and E) Average (D) frequency and (E) amplitude of mEJPs recorded from
abdominal muscle 6 or 7 in GFP control and larvae expressing expanded
htt. Error bars = SEM. Number inside bars is the number of animals studied.
(F) Percent failures measured at 1 Hz in 0.25 mM Ca2+ following stimulation
at two to three times threshold of motor neurons in larvae expressing a non-
toxic GFP protein, wild-type htt, expanded htt or controls carrying the htt
transgene without a GAL4 driver. All experiments done at 29C. Genotypes:
Elav-GFP (Elav-GAL4/+; UAS-GFP/+), Elav-16QhttFL (Elav-GAL4/+; UAS-
16QhttFL[M28]/+), 128QhttFL (UAS-128QhttFL(s)[M36E2]/+), Elav-128QhttFL
(Elav-GAL4/+; UAS-128QhttFL(s)[M36E2]/+).than controls (GMR-GAL4/UAS-GFP) (Figures 2F, 7A, and 7B).
However, animals expressing 128QhttFL in the context of re-
duced function of Snap (GMR-GAL4/+; UAS-128QhttFL(w)[F7]/
SnapM4) show a reversal of this neurodegenerative phenotype
(Figures 7A and 7C, p < 0.001, Mann-Whitney test). Similar results
were also obtained with animals having only one functional copy
of the Syntaxin 1A gene (GMR-GAL4/+; UAS-128QhttFL(w)[F7]/
Syx229, Figures 7A and 7D, p < 0.001, Mann-Whitney test) or the
Rop gene (GMR-GAL4/+; UAS-128QhttFL(w)[F7]/RopG27, Figures
7A and 7E, p < 0.001, Mann-Whitney test). Partial loss of function
of Vha100-1, on the other hand, did not improve the eye degener-
ation (GMR-GAL4/+; UAS-128QhttFL(w)[F7]/vha 1, Figures 7A and
7G, p > 0.5, Mann-Whitney test). Moreover, we observed suppres-
sion of the 128QhttFL external eye phenotype with reduced activity
of the neurotransmitter release gene Syx (Figures 7J–7L). These
data indicate a link between increased neurotransmission and
neuronal degeneration in 128QhttFL animals.
In addition to the eye assay, we tested the ability of one mutant
copy of Syx to suppress the motor performance defects caused
by expression of 128QhttFL in the CNS. Flies expressing 128QhttFL
(C164-GAL4/+; UAS-128QhttFL(s)[M36E2]/+) perform poorly in
the climbing assay relative to controls, but this phenotype is sup-
pressed in 128QhttFL flies that are heterozygous mutant for Syx
(C164-GAL4/+; UAS-128QhttFL(s)[M36E2]/+; Syx229/+; see Fig-
ure 7I). These results validate the fact that loss-of-function muta-
tions in components of the neurotransmitter release machinery
act as suppressors in different assays, and they underscore the
importance of synaptic transmission dysfunction in 128QhttFL-
induced neurodegeneration.
Increased Ca2+ Levels in Synaptic
Terminals of Drosophila Expressing 128QhttFL
Are Restored by Mutations in Components
of the Neurotransmitter Release Machinery
Intracellular Ca2+ levels are elevated in lymphoblasts of HD
mouse models, and expanded htt has been shown to potentiate
NMDAR (NR1/NR2B)-induced apoptosis and Ca2+ transients
(Cepeda et al., 2001; Hodgson et al., 1999; Tang et al., 2005).
Hence, we investigated whether elevated presynaptic Ca2+
levels may account for increased vesicle release at 128QhttFL
synapses by measuring presynaptic Ca2+ levels at the NMJ
of 128QhttFL third-instar larvae. To assess resting intracellular
Ca2+ levels at presynaptic terminals, we forward-filled motor
axons of control and 128QhttFL larvae with the ratiometric dye
Fura-2 Dextran. Upon Ca2+ binding, the maximal excitation
of Fura-2 shifts from 380 nm to 340 nm. Therefore, the fluo-
rescence ratio, F340/F380, provides a relative measure of Ca
2+
levels. We found that resting synaptic Ca2+ levels are elevated
on average by 2-fold in 128QhttFL larvae compared with GFP
controls. A similar effect was also found in 16QhttFL larvae (Fig-
ure 8A). In addition, Ca2+ levels are more variable at 128QhttFL
synapses compared with those of GFP controls (f test,
p < 0.001), with a bimodal distribution of fluorescence ratios
indicative of bouton populations with both normal and aberrant
intracellular Ca2+ levels (Figure 8A; open diamonds denote indi-
vidual data points). This observation concurs with the uneven
distribution of 128QhttFL in synaptic boutons described above
(Figure 4A).Neuron 57, 27–40, January 10, 2008 ª2008 Elsevier Inc. 33
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Reversing Htt-Induced Increased NeurotransmissionFigure 6. Heterozygous Mutations in Genes
Affecting Secretion Suppress the Increased
Release Probability Caused by Full-Length
Expanded htt
(A–H) Quantification of EJP amplitudes (A, C, E,
and G) and percent failures (B, D, F, and H) in lar-
vae expressing a nontoxic control protein GFP,
heterozygous mutant for (A and B) Snap, (C and
D) Rop, (E and F) syntaxin 1A, or (G and H)
Vha100kDa, expressing expanded htt or express-
ing expanded htt as well as heterozygous mutant
for either (A and B) Snap, (C and D) Rop, (E and
F) syntaxin 1A, or (G and H) Vha100-1 at 29C.
Error bars = SEM. Number inside bars is the num-
ber of animals studied. ns, p > 0.05; *p < 0.05;
**p < 0.01. Experiments done at 29C.
(I–N) Sample EJP traces (five consecutive traces
recorded at 1 Hz interval) recorded from (I) larvae
expressing expanded htt, (J) the control protein,
GFP, (K) heterozygous mutant for Snap, (L) ex-
pressing expanded htt and heterozygous mutant
for Snap, (M) heterozygous mutant for Rop and
(N) expressing expanded htt and heterozygous
mutant for Rop. Arrows indicate blanked-out stim-
ulus artifact. All experiments done at 29C. All re-
cordings at 1 Hz in HL3 buffer at 0.25 mM Ca2+.
Genotypes: GFP (Elav-GAL4/+; UAS-GFP/+),
128QhttFL (Elav-GAL4/+; UAS-128QhttFL(s)
[M36E2]/+), SnapM4/+ (Elav-GAL4/+; SnapM4/+),
128QhttFL/SnapM4 (Elav-GAL4/+; UAS-128QhttFL(s)
[M36E2]/+; SnapM4/+), Rop27/+ (Elav-GAL4/+;
RopG27/+), 128QhttFL/RopG27 (Elav-Gal4/+; UAS-
128QhttFL(s)[M36E2]/+; RopG27/+), Syx229/+ (Elav-
GAL4/+; Syx229/+), 128QhttFL/Syx229 (Elav-Gal4/+;
UAS-128QhttFL(s)[M36E2]/+; Syx229/+), vha1/+
(Elav-GAL4/+; vha1/+), 128QhttFL/vha1 (Elav-GAL4/+;
UAS-128QhttFL(s)[M36E2]/+; vha1/+).In order to mediate efficient release, vesicles are positioned
closely to sites of Ca2+ influx via interactions between presynap-
tic release proteins, including syntaxin, SNAP-25, and the syn-
print region of voltage-gated Ca2+ channels (Katz and Miledi,
1965; Swayne et al., 2005). Htt interacts with subunits of volt-
age-gated Ca2+ channels present at the synapse and may func-
tionally alter Ca2+ channel function (Swayne et al., 2005). These
data suggest that, while interactions of expanded htt may inter-
fere with components of the release machinery, they may also
disturb Ca2+ homeostasis at the synapses, resulting in increased
neurotransmitter release.
To investigate whether the elevated presynaptic Ca2+ levels
stem from interactions between expanded htt and the synaptic
release machinery, we determined resting Ca2+ levels in larvae
overexpressing 128QhttFL but lacking one functional copy of
Syx. Compared with animals expressing 128QhttFL alone, which
have elevated synaptic Ca2+ levels (Figures 8A and 8B, Elav-
GAL4/+; UAS-128QhttFL(s)[M36E2]/+: F340/F380 = 0.83 ± 0.42),
128QhttFL animals with only one functional copy of Syx exhibit
a reduction in Ca2+ (Figures 8A and 8B, Elav-GAL4/+; UAS-
128QhttFL(s)[M36E2]/+; Syx229/+: F340/F380 = 0.39 ± 0.07) and
show levels similar to those of controls (Figures 8A and 8B,
Elav-GAL4/+; UAS-GFP/+: F340/F380 = 0.28 ± 0.04). Because34 Neuron 57, 27–40, January 10, 2008 ª2008 Elsevier Inc.voltage-gated Ca2+ channels are critical purveyors of presynaptic
calcium entry and synaptic release, we investigated whether
reduced calcium channel activity also corrects the 128QhttFL-in-
duced elevation in calcium levels. Two Drosophila voltage-gated
Ca2+ channel pore subunits are expressed in neurons (Kawasaki
et al., 2000; Zheng et al., 1995). Dmca1D is an L-type voltage-
gated Ca2+ channel, while Dmca1A, also known as cacophony,
is a P/Q-type voltage-gated channel; both mediate Ca2+ influx
at the presynaptic terminal (Kawasaki et al., 2000; Zheng et al.,
1995). Interestingly, the increased Ca2+ levels are normalized in
128QhttFL-expressing animals with only one functional copy of
Dmca1D (Elav-GAL4/+; UAS-128QhttFL(s)[M36E2]/Dmca1DX10:
F340/F380 = 0.29 ± 0.04). This reduction is not due to the loss of
either Syx or Dmca1D alone because Elav-GAL4/+; Syx229/+
and Elav-GAL4/+; Dmca1Dx10/+ have similar resting Ca2+ levels
as controls (Figure 8A, Elav-GAL4/+; Syx229/+: F340/F380 = 0.30 ±
0.05; Elav-GAL4/+; Dmca1DX10/+: F340/F380 = 0.24 ± 0.05). Be-
cause Ca2+ is required upstream of vesicle fusion, this suggests
that alterations in neurotransmission at synapses that accumu-
late 128QhttFL may stem from an elevation in synaptic Ca2+ levels.
In addition, interactions between 128QhttFL and the vesicle
release machinery may serve to modulate synaptic efficacy by
regulating synaptic Ca2+ levels.
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Reversing Htt-Induced Increased NeurotransmissionFigure 7. HeterozygousMutations inGenesAffectingNeurotransmitter Secretion also Suppress Neurodegeneration andMotor Impairments
in Animals Expressing Expanded Full-Length htt
(A) Number of rhabdomeres per ommatidium in 20-day-old flies of the indicated genotypes. The distribution of the rhabdomeres is significantly different
(p < 0.001, Mann-Whitney test) between 128QhttFL and 128QhttFL animals also carrying one mutant copy of SNAP, Syx, Rop, or Dmca1D. Flies grown at
27C. Genotypes: 128QhttFL (GMR-GAL4/+; UAS-128QhttFL(w)[F7]), 128QhttFL/SnapM4 (GMR-GAL4/+; UAS-128QhttFL(w)[F7]/SnapM4), 128QhttFL/Syx229
(GMR-GAL4/+; UAS-128QhttFL(w)[F7]/Syx229), 128QhttFL/RopG27 (GMR-GAL4/+; UAS-128QhttFL(w)[F7]/RopG27), 128QhttFL/Dmca1DX10 (GMR-GAL4/
Dmca1DX10; UAS-128QhttFL(w)[F7]/+), 128QhttFL/vha1 (GMR-GAL4/+; UAS-128QhttFL(w)[F7]/vha1), GFP (GMR-GAL4/ UAS-GFP).
(B–H) Phalloidin staining of dissected retinas from 20-day-old flies of the genotypes indicated in each panel. Scale bar, 5 mM. Flies grown at 27C. Genotypes: (B),
128QhttFL (GMR-GAL4/+;UAS-128QhttFL(w)[F7]/+); (C), 128QhttFL/SnapM4 (GMR-GAL4/+;UAS-128QhttFL(w)[F7]/SnapM4); (D), 128QhttFL/Syx229 (GMR-GAL4/+;
UAS-128QhttFL(w)[F7]/Syx229); (E), 128QhttFL/RopG27 (GMR-GAL4/+; UAS-128QhttFL(w)[F7]/RopG27); (F), 128QhttFL/Dmca1DX10 (GMR-GAL4/Dmca1DX10; UAS-
128QhttFL(w)[F7]/+); (G), 128QhttFL/Vha1 (GMR-GAL4/+; UAS-128QhttFL(w)[F7]/Vha1); (H), GFP (GMR-GAL4/UAS-GFP).
(I) Suppression of climbing performance phenotype in flies expressing 128QhttFL and heterozygous for a loss-of-function mutation inSyx. Flies expressing the non-
toxic GFP protein or 16QhttFL show normal decline in climbing performance with age. Climbing performance impairment occurs prematurely in flies expressing
128QhttFL, but it is restored in a background heterozygous mutant forSyx. Error bars = SEM of ten trials per time point. Flies grown at 25C. Genotypes: GFP (C164-
GAL4/UAS-GFP), 16QhttFL (C164-GAL4/UAS-16QhttFL[M28]), 128QhttFL (C164-GAL4/UAS-128QhttFL(s)[M36E2]), 128QhttFL/Syx229 (C164-GAL4/UAS-
128QhttFL(s)[M36E2]; Syx229/+).
(J–L) SEM eye images of flies expressing (J) the non-toxic control protein GFP, (K) 128QhttFL (L) 128QhttFL and heterozygous mutant for Syx. Note partial suppres-
sion of the disorganized ommatidia phenotype in Syx heterozygous mutant animals. Genotypes: lacZ (GMR-GAL4(s)/UAS-GFP), 128QhttFL (GMR-GAL4(s)/UAS-
128QhttFL(s)[M36E2]), 128QhttFL(w)/Syx229 (GMR-GAL4(s)/UAS-128QhttFL(s)[M36E2]/+; Syx229/+). Flies grown at 25C.Increased Transmission, Decreased Failures,
and Photoreceptor Degeneration in 128QhttFL Animals
Are Restored by Reducing the Activity of Voltage-Gated
Ca2+ Channels
To test whether Ca2+ levels are a cause of increased transmis-
sion and decreased failures in 128QhttFL animals, we recorded
EJPs at 0.25 mM Ca2+ in Elav-128QhttFL flies that lack one
copy of Dmca1D or Dmca1A (Figures 8C and 8D). As shown in
Figures 8C and 8D, although neither Elav-GAL4; Dmca1Dx10/+
nor Elav-GAL4, Dmca1AHC129 harbor differing EJP amplitudes
or failure rates compared with controls (Elav-GFP), both the
increased EJP amplitude and the decreased failures observed
in Elav-128QhttFL animals are significantly suppressed by re-
moving one copy of either Dmca1D or Dmca1A. Likewise, the
photoreceptor degeneration observed in 128QhttFL-expressing
flies is suppressed by removing one copy of Dmca1D (Figures
7A and 7F; p < 0.001, Mann-Whitney test). These data furthersupport the hypothesis that altered intracellular Ca2+ levels in
neurons that express expanded htt lead to increased release
probability and neuronal degeneration.
DISCUSSION
Here we develop a Drosophila model of HD to investigate the
mechanisms by which expanded full-length human htt causes
neuronal dysfunction and degeneration. Targeted expression of
128QhttFL causes neuronal degeneration (both in eye photore-
ceptors and in the CNS), motor performance impairments,
reduced lifespan, and increased neurotransmitter release. Im-
portantly, these abnormalities occur in the absence of detectable
htt nuclear import or axonal blockages and are specific to
128QhttFL, because expression of similar levels of wild-type
16QhttFL does not cause abnormal phenotypes.Neuron 57, 27–40, January 10, 2008 ª2008 Elsevier Inc. 35
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Reversing Htt-Induced Increased NeurotransmissionFigure 8. Increased Ca2+ Levels Caused by Expanded
Full-Length htt Can Be Suppressed Genetically
(A) Fluorescence ratios (F340/F380) measured from fura dex-
tran-filled larval NMJs. Neuronal expression of 128QhttFL and
16QhttFL leads to increased fluorescence ratios compared to
controls (GFP), indicating elevated resting Ca2+ levels at these
synapses (*p < 0.05, t test). These elevated fluorescence ratios
are normalized in 128QhttFL animals that are also heterozygous
for either Syntaxin or Dmca1D mutations (*p < 0.05, t test). Ge-
notypes: Elav-Gal4/+; UAS-128QhttFL(s)[M36E2]/+; Syx229/+
and Elav-GAL4/+; UAS-128QhttFL(s)[M36E2]/Dmca1DX10. Note
that animals carrying Syx or Dmca1D heterozygous mutations
but no htt transgene show no effect on resting Ca2+ levels com-
pared to GFP controls. Genotypes: Elav-GAL4/+; Syx229/+ and
Elav-GAL4/+; Dmca1DX10/+. Boutons were measured from
two to three synapses in six larvae per genotype. Dots denote
single data points from individual boutons.
(B) Fluorescence from boutons forward-filled with fura dextran
and excited at both 340 nm and 380 nm. Ca2+-free dye absorbs
optimally at 380 nm while Ca2+-bound dye is excited primarily at
340 nm. NMJ synapses loaded with fura dextran were clearly vi-
sualized (top panel) and individual boutons could be spatially re-
solved (dashed box). In contrast to controls (Elav-GAL4/+; UAS-
GFP/+), NMJ boutons from larvae expressing expanded htt
(Elav-GAL4/+; UAS-128QhttFL(s)[M36E2]/+) emit more intensely
when excited at 340 nm compared to 380 nm. However, Syx
heterozygosity (Elav-Gal4/+; UAS-128QhttFL(s)[M36E2]/+;
Syx229/+) alleviates this phenotype.
(C and D) Quantification of EJP amplitudes and percent failures
recorded at 1Hz in 0.25 mM Ca2+ in larvae expressing a nontoxic
GFP control protein, expressing 128QhttFL, heterozygous mutant forDmca1D (C),Dmca1A (D), or expressing 128QhttFL as well as heterozygous mutant for either
Dmca1D (C) or Dmca1A (D). All experiments at done at 29C. Error bars = SEM. The number of recordings from at least 3 animals is indicated inside the bars. ns,
p > 0.05; *p < 0.05; **p < 0.01 throughout the figure. Genotypes: GFP (Elav-GAL4/+; UAS-GFP/+), 16QhttFL (Elav-GAL4/+; UAS-16QhttFL(s)[M28]/+), 128QhttFL
(Elav-GAL4/+; UAS-128QhttFL(s)[M36E2]/+), Syx229/+ (Elav-GAL4/+; Syx229/+), 128QhttFL/Syx229 (Elav-Gal4/+; UAS-128QhttFL(s)[M36E2]/+; Syx229/+),
Dmca1DX10/+ (Elav-GAL4/+; Dmca1DX10/+), 128QhttFL/Dmca1DX10 (Elav-GAL4/+; UAS-128QhttFL(s)[M36E2]/Dmca1DX10), Dmca1AHC129/+ (Elav-GAL4/
Dmca1AHC129), 128QhttFL/Dmca1AHC129 (Elav-GAL4/Dmca1AHC129; UAS-128QhttFL(s)[M36E2]/+).Expression of 128QhttFL in the eye using GMR-GAL4 leads to
progressive photoreceptor neuron degeneration. Histological
examination of the internal eye structure in flies of different
ages reveals that the number and arrangement of rhabdomeres
in photoreceptor cells is relatively normal in 1-day-old flies
(Figure 2E), but degeneration is evident at day 20 (Figure 2F). Ex-
pression of 128QhttFL in motor neurons leads to motor impair-
ment phenotypes. The 128QhttFL animals perform as controls
do in a climbing assay when they are young, but their motor
performance declines prematurely as they age. Moreover, flying
ability is impaired in aged 128QhttFL flies, and they also show
progressive loss of NMJs at the IFM. In addition, these flies
show a reduced survival rate when compared with controls
(Figures 3A–3E).
These neurodegenerative phenotypes are not likely a conse-
quence of transcriptional dysregulation, because they occur
in the absence of obvious nuclear htt, even in aged flies. We
also investigated the possibility that axonal blockages trigger
the phenotypes observed in 128QhttFL flies; axonal blockages
and impaired fast axonal transport have been reported following
expression of polyglutamine tracts alone or in the context of
other polypeptides (Gunawardena et al., 2003), including ex-
panded htt (Lee et al., 2004). However, we did not detect htt or
synaptotagmin accumulation in the axons of 128QhttFL flies,
even though we could reproduce the observation of axonal
blockages reported with an expanded htt fragment (Figures 1C36 Neuron 57, 27–40, January 10, 2008 ª2008 Elsevier Inc.and 1D). Despite the absence of visible htt or synaptotagmin ag-
gregates, the possibility that intracellular transport is decreased
cannot be excluded (Szebenyi et al., 2003; Gauthier et al., 2004).
However, we did not observe mislocalization or aberrant distri-
bution of known synaptic markers that rely on vesicular transport
for their proper synaptic localization (Figure 4B).
All together, these data suggest that the presynaptic accumu-
lation of 128QhttFL impairs the function of factors involved in
neurotransmitter release. This hypothesis agrees with abundant
data describing protein interactions between htt and compo-
nents of the synaptic machinery (Smith et al., 2005) and with find-
ings in R6/1 and R6/2 mouse models that suggested a role for
altered neurotransmitter release as a potential mechanism of
HD pathogenesis. In R6/2 mice, synapsin phosphorylation is
partially defective (Lievens et al., 2002), and in R6/1 mice gluta-
mate levels are reduced and aspartate and GABA are increased
(Nicniocaill et al., 2001). Moreover, increased NMDA receptor
activity has been reported in full-length HD mice (Cepeda
et al., 2001; Zeron et al., 2002), leading to a postsynaptic in-
crease in Ca2+ influx and abnormal synaptic transmission. In ad-
dition, Ca2+ levels were found to be increased by almost 2-fold in
CA1 pyramidal neurons in full-length HD mice (Hodgson et al.,
1999). However, no defects were observed in paired-pulse facil-
itation, which questions the biological relevance of this finding. In
addition, mutant htt has been implicated in aberrant mitochon-
drial Ca2+ buffering (Panov et al., 2005), and it also increases
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Reversing Htt-Induced Increased Neurotransmissionthe sensitivity of the inositol 1,4,5-triphosphate (IP3) receptor to
IP3, causing enhanced Ca
2+ release following mGluR1/5 activa-
tion (Tang et al., 2003). These data suggest that cytosolic Ca2+
levels play a role in HD pathogenesis (Bezprozvanny and Hay-
den, 2004).
To test whether expanded htt impairs the normal function of
proteins involved in synaptic transmission, we used a genetic
approach using the 128QhttFL animals. We found that partial
loss of function of Snap, syntaxin, or Rop restores the increased
EJP amplitude observed in 128QhttFL larvae to near-normal
levels (Figures 6A, 6C, and 6E). Moreover, the lack of neurotrans-
mitter release failures is also suppressed by these mutations
(Figures 6B, 6D, and 6F). These observations suggest that neu-
rodegeneration in 128QhttFL flies is caused by increased synap-
tic transmission. In agreement with this hypothesis, we found
a progressive neurodegenerative phenotype in the NMJ of adult
128QhttFL animals (Figures 3D and 3E). Most importantly, further
support for this hypothesis comes from the observation that the
same synaptic transmission mutants that restore the EJP ampli-
tude and release failure abnormalities also suppress motor
impairment, photoreceptor degeneration, or both in 128QhttFL
adult animals (Figure 7 and Figure S1, available online).
Ca2+ levels have a bimodal distribution in 128QhttFL flies, with
some boutons showing high Ca2+ levels and other boutons
within the same neuromuscular junction showing levels in the
normal range (Figure 8A, note also that 16QhttFL flies show a
similar effect). This distribution can be correlated with the accu-
mulation pattern of htt, which is present in some boutons and ab-
sent in others within a given neuromuscular junction (Figure 4A).
We tested the hypothesis that Ca2+ levels are relevant for the
increased transmission and decreased failures observed in
128QhttFL animals using mutations in voltage-gated Ca2+ chan-
nels. We found that Ca2+ levels are restored within normal range
in 128QhttFL flies carrying heterozygous mutations in either Syx
or the Dmca1D Ca2+ channel (Figures 8A and 8B). Furthermore,
heterozygous mutants for either the Dmca1A or Dmca1D Ca2+
channels also show suppression of the increased transmission
and decreased failure phenotypes (Figures 8C and 8D). We
also tested Dmca1D in the context of the eye assay and found
that its partial loss of function suppresses photoreceptor degen-
eration (Figures 7A and 7F). These data support the hypothesis
that increased Ca2+ levels play an important role in the observed
increased transmission in neurons of 128QhttFL animals. Inter-
estingly, mutations in K+ channels cause neurodegeneration in
flies (Fergestad et al., 2006) and in humans (Waters et al.,
2006), further supporting the idea that the increased release is
responsible, at least in part, for neuronal degeneration caused
by expanded htt.
The findings described in this report unveil a mechanism of
pathogenesis for expanded htt that does not require its nuclear
accumulation in detectable amounts. The increased synaptic
transmission phenotype exerted by full-length htt likely repre-
sents a mechanism of pathogenesis taking place at early stages
of disease progression. In later stages, cleavage of htt would
compound the toxic effects of the full-length protein with fast
axonal transport impairments and transcriptional dysregulation
caused by N-terminal fragments. These findings point to in-
creased synaptic transmission as a therapeutic target with thepotential of delaying HD onset and thus likely impacting disease
progression. The genetic data showing suppression of the syn-
aptic transmission and neurodegenerative phenotypes further
define specific therapeutic targets and support the idea that
Ca2+ channel antagonists, and perhaps other inhibitors of neuro-
transmission, offer an attractive therapeutic option due to their
specificity and wide usage.
EXPERIMENTAL PROCEDURES
Generation of Htt Constructs and Strains
The 128QhttFL cDNA was generated by replacing an N-terminal fragment of
a 16QhttFL cDNA (provided by Dr. Tagle, NIH) with the corresponding 128Q
N-terminal fragment (Kaltenbach et al., 2007). The constructs were subse-
quently cloned into the pUAST vector (Brand and Perrimon, 1993) and injected
in the y1w118 strain by standard procedures. Four 128QhttFL and three
16QhttFL lines were generated. GMR and Elav-GAL4 drivers were obtained
from the Bloomington Stock Center, GMR(s)-GAL4 from Dr. P. Jin (Emory
Univ. School Med.), C164-GAL4 from Dr. V. Budnik, (Univ. Massachusetts,
Amherst), and apVNC–GAL4 was generated in our lab. Snap mutants were ob-
tained from Dr. L.J. Pallanck (Univ. Washington, Seattle), and Rop, Syx, vha
mutants were generated in the Bellen lab. Dmca1DX10 mutants were obtained
from Dr. L. Hall (Univ. California, Davis) and Dmca1AHC129 mutants were
obtained from Dr. R. Ordway (Penn State Univ.).
Western Blot Analysis
To assess htt protein levels, pUAST-htt lines were crossed with the GMR-Gal4
driver at 27C. Eight females per genotype were aged 1 day before isolating
heads and homogenizing in sample buffer containing 8 M urea followed by
boiling. Proteins were separated on 4%–20% gradient SDS/PAGE gels (BIO-
RAD). After electrophoresis, gels were electroblotted overnight onto nitrocellu-
lose membranes. The membranes were immunoblotted with anti-htt (MAB2166,
Chemicon) at 1:2000, and immunoreactive bands were visualized using ECL
western blotting detection reagents from Amersham. Densitometry analysis
was done using a Molecular Dynamics Personal Densitometer SI and analyzed
with Image Quant 5.2 software.
Immunohistochemistry and Histology
Immunohistochemistry was performed as described (Fernandez-Funez et al.,
2000; Verstreken et al., 2003) with the following modifications. Larvae and
adult tissue was fixed in 4% formaldehyde for 1 hr and washed in 1XPBS
with 0.1% Triton X-100. For GluRIIA labeling, larvae were fixed in 50% picric
acid, 2.5% formaldehyde in 1XPBS for 20 min, and washed in 1XPBS with
0.1% Triton X-100. After blocking with 2% BSA, samples were incubated
with primary antibodies overnight. Primary antibodies were used at the follow-
ing concentrations: htt MAB5374 (1:200, Chemicon), HRP (1:500), GFP (1:200),
Syt (1:200), Dlg (1:200), GluIIRA (1:100), Rop (1:100), SNAP (1:100), and syn-
taxin (1:200). After washing steps, secondary antibodies conjugated to Cy3
or Alexa 488 (Jackson Immunolabs, Molecular Probes) were used at 1:200.
Phalloidin staining to monitor rhabdomere degeneration was performed as
described (Sang and Ready, 2002). Adult eye retinas were removed from the
head capsule in 4% formaldehyde and fixed for 1 hr. Fixed, dissected eyes
were washed in PBS, 0.1% Triton X-100 and incubated in phalloidin (1:200,
Molecular Probes).
For visualizing the neuronal projections into IFMs, fixed adult thoraxes from
25-day-old adult flies were dissected along the midline, and neurons were
labeled with anti-HRP antibody. The number of neuronal projections was
counted in confocal stacks of a specified 100 mm 3 100 mm area of IFMs 3
and 4 (located 100 mm away from the cuticle, shown in Figure 3D) using the
whole-mount preparation of each hemithorax.
All immunostained samples were visualized using a Zeiss 510 confocal
microscope, and ImageJ Software was used to obtain a 2D image by stacking
the optically sectioned images. These stacked images were used for further
analysis. Image panels were processed using Photoshop.Neuron 57, 27–40, January 10, 2008 ª2008 Elsevier Inc. 37
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taken with a Leica MZ16 stereomicroscope using a MagnaFire SP Digital Cam-
era, and images were collected with Image-Pro Plus 4.5 Analytical Imaging
Software. For SEM images, whole flies were dehydrated in ethanol, critical-
point dried, and analyzed with a JEOL JSM 6100 E.M.
Adult Behavioral Assays
Climbing assays were performed on virgin female flies. Approximately 30 flies
were placed in a plastic vial and gently tapped to the bottom of the vial. The
number of flies above the 5 cm line after 18 s were counted and recorded.
Ten trials were performed at each time point. The results shown represent
the performance of one batch of flies tested over 30 days.
Flying tests were performed on 25-day-old female virgins. Flying ability was
estimated by measuring flying distances after they were dropped from the top
of a transparent plastic cylinder as described (Pesah et al., 2004).
Larval Electrophysiological Assays
Third-instar physiology was performed as described (Verstreken et al., 2003).
L3 NMJ recordings were performed in modified HL3 containing 110 mM NaCl,
5 mM KCl, 10 mM NaHCO3, 5 mM HEPES, 30 mM sucrose, 5 mM trehalose,
5 mM CaCl2, and 20 mM MgCl2 (pH 7.2). mEJPs were recorded in modified
HL-3 with 5 mM TTX and 0.5 mM Ca2+. Current-clamp recordings were
made from muscles 6 or 7 using high-resistance electrodes (100 MU) filled
with 2 M KAc and 0.2 M KCl. EJPs were evoked at two times to three times
threshold using a suction electrode. Data were digitized and stored on a PC
with pClamp and analyzed with Clampfit (Axon) or Mini analysis (Synaptosoft).
EJP amplitudes in low Ca2+ were determined using only the successful
events.
Larval Ca2+ Imaging
After dissecting larvae in Schneider’s medium (GIBCO), a drop (20 ml) of
5 mM Fura-2 Dextran (Invitrogen) was placed on the preparation, and a small
amount of dye as well as a cut motor axon taken into a suction electrode.
Excess dye was removed and the preparation washed and incubated in
Schneider’s medium for 40 min. Following dye loading, Schneider’s me-
dium was replaced with modified HL3 containing 110 mM NaCl, 5 mM KCl,
10 mM NaHCO3, 5 mM HEPES, 30 mM sucrose, 5 mM trehalose, and
20 mM MgCl2 (pH 7.2), with 1 mM Ca
2+. Images were obtained after allowing
the preparation to equilibrate with HL3 for 15 min. Excitation at 340 nm
and 380 nm was aided by a filter wheel (Sutter Lambda 10-2) and fluores-
cence images collected using a 403 water-immersion objective (Zeiss Achro-
plan) and Zeiss AxioCam MRm CCD camera. Images were processed with
Amira 2.2.
Supplemental Data
The Supplemental Data for this article can be found online at http://www.
neuron.org/cgi/content/full/57/1/27/DC1/.
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